Efficacy of Rifaximin as an Adjunct Treatment for Levodopa induced dyskinesia: Preliminary Results
Objective: To evaluate the efficacy of rifaximin as an adjunct treatment for LID (levodopa induced dyskinesia) in patients with PD through a randomized, double-blind, placebo-controlled…Validation of a quantitative test using kinesiological evaluation of upper extremity movements in patients with Parkinson’s disease: A pilot study.
Objective: To establish the validity of an upper extremity kinesiological assessment in patients with Parkinson's disease as a complementary tool to clinical instruments. Background: Parkinson's…Characteristics and Trends of Parkinson’s Disease Patients Receiving Deep Brain Stimulation: Insights From a US All-Payer Health Administrative Claims Database
Objective: To describe sociodemographics, treatment patterns, and costs among Parkinson’s patients who received deep brain stimulation (DBS) in the United States (US). Background: Parkinson’s disease…Prevalence of Central Pain in Parkinson’s Disease: A Systematic Review and Meta-analysis
Objective: In this systematic review and meta-analysis, we aimed to evaluate the prevalence of central pain and how this symptom may affect the patient's quality…Exploring the ubiquitome in Parkinson’s Disease
Objective: To explore the role of ubiquitin signalling defects in Parkinson’s Disease. Background: Defects in ubiquitin signalling have been implicated in the pathogenesis of neurodegenerative…Apolipoprotein E ɛ4-allele and Amygdala Atrophy in Parkinson’s Disease: A Preliminary Longitudinal Analysis from the ONDRI Cohort
Objective: To investigate the association of apolipoprotein E ɛ4-allele (APOE-ε4) with amygdala volumes longitudinally in Parkinson’s disease (PD). Background: APOE-ε4 is a genetic risk factor…Exploring Neuroprotective Role of Natural Compound by Targeting c-Abl Kinase in Parkinson’s Disease
Objective: To explore c-Abl kinase activation and neuron death pathway in Parkinson’s Disease (PD) mouse model. Assess neuroprotection natural compounds, Rosmarinic acid (RA) with proven…Evaluation of Perfusion, Iron Deposition, and Neuromelanin MRI Biomarkers Following Mesenchymal Stem Cell Treatment in a Phase 2 Parkinson’s Disease Trial
Objective: Evaluate the effects of allogeneic bone marrow-derived mesenchymal stem cell (allo-hMSC) infusions on neuroimaging biomarkers in patients with Parkinson’s disease (PD) using different MRI…Subthalamic nucleus DBS outcomes correlate with white matter tractography in Parkinson’s Disease
Objective: To assess whether advanced diffusion magnetic resonance imaging (dMRI) techniques help to understand the outcome of Deep brain stimulation (DBS) surgery on Unified Parkinson’s…Understanding the relationship between synaptic density and dopamine transporter availability in Parkinson’s disease
Objective: To evaluate how disease duration in PD affects the coupling of DAT (18F-FE-PE2I) and SV2A density (11C-UCB-J) in the nigrostriatal regions (where both tracers…
- « Previous Page
- 1
- …
- 185
- 186
- 187
- 188
- 189
- …
- 553
- Next Page »